AU688459B2 - Oxopyridinylquinoxaline derivative - Google Patents

Oxopyridinylquinoxaline derivative Download PDF

Info

Publication number
AU688459B2
AU688459B2 AU16256/95A AU1625695A AU688459B2 AU 688459 B2 AU688459 B2 AU 688459B2 AU 16256/95 A AU16256/95 A AU 16256/95A AU 1625695 A AU1625695 A AU 1625695A AU 688459 B2 AU688459 B2 AU 688459B2
Authority
AU
Australia
Prior art keywords
nitro
lower alkyl
hydrogen
halogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU16256/95A
Other languages
English (en)
Other versions
AU1625695A (en
Inventor
Makoto Adachi
Nobuo Chomei
Masami Eigyo
Kazuo Kawasaki
Susumu Takada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU1625695A publication Critical patent/AU1625695A/en
Application granted granted Critical
Publication of AU688459B2 publication Critical patent/AU688459B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AU16256/95A 1994-04-08 1995-04-05 Oxopyridinylquinoxaline derivative Ceased AU688459B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7090994 1994-04-08
JP6-70909 1994-04-08

Publications (2)

Publication Number Publication Date
AU1625695A AU1625695A (en) 1995-10-19
AU688459B2 true AU688459B2 (en) 1998-03-12

Family

ID=13445121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16256/95A Ceased AU688459B2 (en) 1994-04-08 1995-04-05 Oxopyridinylquinoxaline derivative

Country Status (14)

Country Link
US (1) US5677305A (enExample)
EP (1) EP0676397B1 (enExample)
KR (1) KR100363003B1 (enExample)
CN (1) CN1044241C (enExample)
AT (1) ATE185806T1 (enExample)
AU (1) AU688459B2 (enExample)
CA (1) CA2146478A1 (enExample)
DE (1) DE69512816T2 (enExample)
DK (1) DK0676397T3 (enExample)
ES (1) ES2140620T3 (enExample)
GR (1) GR3032406T3 (enExample)
HU (1) HUT72064A (enExample)
TW (1) TW300894B (enExample)
ZA (1) ZA952841B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
AUPN842196A0 (en) * 1996-03-05 1996-03-28 Fujisawa Pharmaceutical Co., Ltd. New compound
HUP0002853A3 (en) * 1997-09-01 2001-12-28 Kyorin Seiyaku Kk 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
PL344406A1 (en) 1998-06-01 2001-11-05 Shionogi & Co Cyanoiminoquinoxaline derivatives
CN101248060B (zh) * 2005-06-23 2014-09-10 阵列生物制药公司 用于制备苯并咪唑化合物的方法
WO2010053757A1 (en) * 2008-10-29 2010-05-14 Gilead Palo Alto, Inc. 2 -oxoquinoxalin blockers of the late sodium channel
WO2010074807A1 (en) 2008-10-30 2010-07-01 Gilead Palo Alto, Inc. 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
CN103664806B (zh) * 2013-12-16 2016-06-29 山东汇海医药化工有限公司 一种n-乙酰乙酰基-6-甲氧基-7-氨基喹喔啉-2，3-二酮的制备方法
US20190382346A1 (en) 2017-02-28 2019-12-19 Universitat Autonoma De Barcelona (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
WO2019161917A1 (en) 2018-02-23 2019-08-29 Universitat Autonoma De Barcelona 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies
WO2024083850A1 (en) 2022-10-18 2024-04-25 ETH Zürich Electrocatalyst

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
JP2635662B2 (ja) * 1987-03-23 1997-07-30 ノボ・ノルデイスク・アクツイエルスカブ ヘテロ環状化合物，その製造方法及びその使用法
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
JPH04193876A (ja) * 1990-11-26 1992-07-13 Sumitomo Chem Co Ltd キノキザリン誘導体、その製造法およびそれを有効成分とする除草剤
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
JPH06228112A (ja) * 1993-02-05 1994-08-16 Yamanouchi Pharmaceut Co Ltd （１ｈ，４ｈ）キノキサリン誘導体
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative

Also Published As

Publication number Publication date
DE69512816T2 (de) 2000-04-27
CA2146478A1 (en) 1995-10-09
CN1044241C (zh) 1999-07-21
KR100363003B1 (ko) 2003-02-11
GR3032406T3 (en) 2000-05-31
US5677305A (en) 1997-10-14
TW300894B (enExample) 1997-03-21
HUT72064A (en) 1996-03-28
DK0676397T3 (da) 2000-04-03
DE69512816D1 (de) 1999-11-25
ATE185806T1 (de) 1999-11-15
HU9501026D0 (en) 1995-06-28
EP0676397B1 (en) 1999-10-20
ES2140620T3 (es) 2000-03-01
AU1625695A (en) 1995-10-19
KR950032171A (ko) 1995-12-20
ZA952841B (en) 1995-12-18
EP0676397A1 (en) 1995-10-11
CN1123792A (zh) 1996-06-05

Similar Documents

Publication Publication Date Title
AU634553B2 (en) Heteroarylamino- and heteroaryloxy-pyridinamines and related compounds, a process for their preparation and their use as medicaments
Ohmori et al. 6-(1H-imidazol-1-yl)-7-nitro-2, 3 (1H, 4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor
US5639752A (en) Indole derivatives
Hubschwerlen et al. Pyrimido [1, 6-a] benzimidazoles: a new class of DNA gyrase inhibitors
Leach et al. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo [3, 2-c] quinolines: effect of the 4-substituent
JPWO1992007847A1 (ja) 縮合ピラジン誘導体
Keana et al. Synthesis and structure-activity relationships of substituted 1, 4-dihydroquinoxaline-2, 3-diones: Antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors
EP0676397B1 (en) Oxopyridinylquinoxaline derivatives
HU223945B1 (hu) 1,2,3,4-Tetrahidro-kinoxalin-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
US6348461B1 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
US5777114A (en) Spiro heterocycle-imidazo 1,2-a!indeno 1,2-e!pyrazine!-4'-ones, preparation thereof and drugs containing same
US5789406A (en) Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them
Katla et al. Synthesis of novel phosphorylated guanidine derivatives from cyanamide and their anti-inflammatory activity
HUT72501A (en) Derivatives of 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, preparation thereof and medicaments containing them
CN113754635A (zh) 稠环类化合物及其制备方法和用途
Moormann et al. Potential antisecretory antidiarrheals. 2.. alpha. 2-Adrenergic 2-[(aryloxy) alkyl] imidazolines
ES2230685T3 (es) Quinoxalinadionas.
JPS60104064A (ja) イソインドール利尿性誘導体
US5066654A (en) 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants
JPH10509131A (ja) 新規キノキサリンおよび該キノキサリンからなる医薬品
US4581349A (en) Certain benzodiimidazoles and their use as radiation sensitizers
Hynes et al. Synthesis of 5-chloro-5, 8-dideaza analogs of folic acid and aminopterin targeted for colon adenocarcinoma
JP2889150B2 (ja) オキソピリジニルキノキサリン誘導体
Abdel-latif Heterocycles synthesis through reactions of indolin-2-one derivatives with active methylene and amino reagents, part 3, novel and facile one-step synthesis of spirothiopyran-4-yl indolidene derivatives
Agasimundin et al. Annelation of isocytosines by reaction with methyl N-cyanomethanimidate and sodium methoxide: influence of substitution on the course of the reaction and rearrangements

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired